(Q39512542)

English

Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial

scientific article published on December 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

phase III clinical trial

0 references

Japanese encephalitis virus

0 references

1 reference

based on heuristic

inferred from title

Japanese encephalitis

1 reference

based on heuristic

inferred from title

Japanese encephalitis vaccine

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Herwig Kollaritsch

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

object named as

E Tauber

1

0 references

author name string

M Korinek

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

P Rendi-Wagner

4

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

B Jilma

5

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

C Firbas

6

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

S Schranz

7

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

E Jong

8

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

A Klingler

9

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

S Dewasthaly

10

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

C S Klade

11

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

language of work or name

0 references

publication date

1 December 2007

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

370

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

9602

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1847-1853

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Control of Japanese encephalitis--within our grasp?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961780-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Japanese Encephalitis Outbreak, India, 2005.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961780-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961780-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961780-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of single dose of SA 14-14-2 vaccine 1 year after immunisation in Nepalese children with Japanese encephalitis: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961780-2

7 January 2021

based on heuristic

inferred from DOI database lookup

New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15 October 1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961780-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Protection against Japanese encephalitis by inactivated vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961780-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Yellow fever and Japanese encephalitis vaccines: indications and complications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961780-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis anti

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961780-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Review on flavivirus vaccine development. Proceedings of a meeting jointly organised by the World Health Organization and the Thai Ministry of Public Health, 26-27 April 2004, Bangkok, Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961780-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Passive immunity for arbovirus infection. I. Artificially induced prophylaxis in man and mouse for Japanese (B) encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961780-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A Phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961780-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Behavioural disturbances following Japanese B encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961780-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Japanese encephalitis in a swedish tourist after travelling to Java and Bali

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961780-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Japanese encephalitis vaccine for travelers: exploring the limits of risk.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961780-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Fury after children's adverse reaction to Japanese encephalitis vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961780-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Neurological complications and Japanese encephalitis vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961780-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Adverse reactions to Japanese encephalitis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961780-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Side-effects with Japanese encephalitis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961780-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Live flavivirus vaccines: reasons for caution

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961780-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Arguments for live flavivirus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961780-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Short-term safety of live attenuated Japanese encephalitis vaccine (SA14-14-2): results of a randomized trial with 26,239 subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961780-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Points to consider in the development of a surrogate for efficacy of novel Japanese encephalitis virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961780-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961780-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Measles antibody: reevaluation of protective titers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961780-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Myopericarditis following smallpox vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961780-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Proinflammatory mediators released by activated microglia induces neuronal death in Japanese encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961780-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(07)61780-2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39512542&oldid=1833830808"